Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Infectious Disease Clinics of North America
|
January 9, 2004
Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid
William A Craig
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 29, 2014
Editorial commentary: Are blood concentrations enough for establishing pharmacokinetic/pharmacodynamic relationships?
William A Craig
The American Journal of Medicine
|
September 14, 2004
Overview of newer antimicrobial formulations for overcoming pneumococcal resistance
William A Craig
Critical Care Clinics
|
December 15, 2010
Optimizing aminoglycoside use
William A Craig
The New England Journal of Medicine
|
May 13, 2011
Fidaxomicin for Clostridium difficile Infection
Nasia Safdar, William A Craig
Antimicrobial Agents and Chemotherapy
|
February 20, 2007
In vivo pharmacodynamic activity of the glycopeptide dalbavancin
David Andes, William A Craig
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 14, 2006
Tigecycline: a critical analysis
Gary E Stein, William A Craig
The Journal of Antimicrobial Chemotherapy
|
April 6, 2019
In vivo pharmacodynamics of lefamulin, the first systemic pleuromutilin for human use, in a neutropenic murine thigh infection model
Wolfgang W Wicha, William A Craig, David Andes
Journal of Bacteriology
|
May 20, 2003
Quantitation of mecA transcription in oxacillin-resistant Staphylococcus aureus clinical isolates
Adriana E Rosato, William A Craig, Gordon L Archer
Diagnostic Microbiology and Infectious Disease
|
December 8, 2004
The inoculum effect: fact or artifact?
William A Craig, Sujata M Bhavnani, Paul G Ambrose
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Infectious Disease Clinics of North America
|
January 9, 2004
Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid
William A Craig
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 29, 2014
Editorial commentary: Are blood concentrations enough for establishing pharmacokinetic/pharmacodynamic relationships?
William A Craig
The American Journal of Medicine
|
September 14, 2004
Overview of newer antimicrobial formulations for overcoming pneumococcal resistance
William A Craig
Critical Care Clinics
|
December 15, 2010
Optimizing aminoglycoside use
William A Craig
The New England Journal of Medicine
|
May 13, 2011
Fidaxomicin for Clostridium difficile Infection
Nasia Safdar, William A Craig
Antimicrobial Agents and Chemotherapy
|
February 20, 2007
In vivo pharmacodynamic activity of the glycopeptide dalbavancin
David Andes, William A Craig
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 14, 2006
Tigecycline: a critical analysis
Gary E Stein, William A Craig
The Journal of Antimicrobial Chemotherapy
|
April 6, 2019
In vivo pharmacodynamics of lefamulin, the first systemic pleuromutilin for human use, in a neutropenic murine thigh infection model
Wolfgang W Wicha, William A Craig, David Andes
Journal of Bacteriology
|
May 20, 2003
Quantitation of mecA transcription in oxacillin-resistant Staphylococcus aureus clinical isolates
Adriana E Rosato, William A Craig, Gordon L Archer
Diagnostic Microbiology and Infectious Disease
|
December 8, 2004
The inoculum effect: fact or artifact?
William A Craig, Sujata M Bhavnani, Paul G Ambrose
Page
of 4